Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

0.3236
+0.00842.66%
Post-market: 0.33260.0090+2.78%19:31 EDT
Volume:246.41K
Turnover:79.77K
Market Cap:23.00M
PE:-0.87
High:0.3295
Open:0.3235
Low:0.3145
Close:0.3152
Loading ...
Nov 22, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 22, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 01, 2019

Major Issues Report

Current report, items 5.01, 8.01, and 9.01
Oct 08, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 07, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Sep 24, 2019

Major Issues Report

Current report, items 5.03 and 9.01
Sep 23, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Sep 19, 2019

Major Issues Report

Current report, items 3.02, 5.03, 5.07, and 9.01
Sep 12, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 09, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 07, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 27, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jun 27, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 18, 2019

Major Issues Report

Current report, items 8.01 and 9.01